Chris Byrne's Avatar

Chris Byrne

@chrbyrne

Public Health Scotland & University of Dundee. Interested in the liver, illicit drug use. https://discovery.dundee.ac.uk/en/persons/chris-byrne-2

194
Followers
490
Following
2
Posts
14.12.2024
Joined
Posts Following

Latest posts by Chris Byrne @chrbyrne

Visual abstract

Visual abstract

Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health markers like high blood pressure, finds new BMJ Research.

Regain was faster than after behavioural weight management programmes
t.co/DOHTIlVzrE

08.01.2026 09:44 πŸ‘ 20 πŸ” 21 πŸ’¬ 3 πŸ“Œ 3
course schedule as a table. Available at the link in the post.

course schedule as a table. Available at the link in the post.

I'm teaching Statistical Rethinking again starting Jan 2026. This time with live lectures, divided into Beginner and Experienced sections. Will be a lot more work for me, but I hope much better for students.

I will record lectures & all will be found at this link: github.com/rmcelreath/s...

09.12.2025 13:58 πŸ‘ 659 πŸ” 235 πŸ’¬ 12 πŸ“Œ 20

Word of the day is β€˜forwallowed’ (15th century): extremely weary from tossing and turning all night.

01.07.2025 07:28 πŸ‘ 3276 πŸ” 669 πŸ’¬ 137 πŸ“Œ 96

🀣🀣 Off her head

28.06.2025 12:29 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
The figure shows the percentage of patients with fibrosis stage 2 or 3 who had resolution of steatohepatitis with no worsening of liver fibrosis (Panel A) and reduction in liver fibrosis with no worsening of steatohepatitis (Panel B) after 72 weeks, with the estimated difference expressed in percentage points.

The figure shows the percentage of patients with fibrosis stage 2 or 3 who had resolution of steatohepatitis with no worsening of liver fibrosis (Panel A) and reduction in liver fibrosis with no worsening of steatohepatitis (Panel B) after 72 weeks, with the estimated difference expressed in percentage points.

In this interim analysis of a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly semaglutide improved liver histologic results at 72 weeks. Full ESSENCE trial results: nej.md/3EVFAFM

#MedSky #EndoSky #GastroSky

30.04.2025 21:10 πŸ‘ 20 πŸ” 9 πŸ’¬ 0 πŸ“Œ 1
Preview
Public-health experts should be more political, not less Health has always been political, long before Donald Trump and Robert F. Kennedy Jr took power. Denying this is what’s been killing us.

β€œThe real crisis is not that public health β€” which is fundamentally about policies dictating the distribution of resources required to protect human life β€” has been politicized. It is that it has not been politicized nearly enough,” writes Eric Reinhart in Nature. πŸ§ͺ

13.03.2025 19:12 πŸ‘ 35 πŸ” 10 πŸ’¬ 1 πŸ“Œ 1

The general trend is crazy. Here is Twitter vs Bluesky volumes for the last week. On some days they are equal in volume.

10.03.2025 15:01 πŸ‘ 462 πŸ” 150 πŸ’¬ 10 πŸ“Œ 14

Every year, there are an estimated 833 760 (95% UI 493 716–1 544 395) new HCV infections attributable to injecting drug use globally

The global decline needed to meet the 2030 WHO target is 76Β·7% (95% UI 71Β·8–81Β·3)

#HepSky #IDSky #MedSky #LiverSky

25.02.2025 12:42 πŸ‘ 7 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
Preview
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment Nature Reviews Gastroenterology & Hepatology, Published online: 17 February 2025; doi:10.1038/s41575-025-01045-zThis Review discusses the link between metabolic dysfunction-associated steatotic liver disease (MASLD) β€” a heterogeneous health condition —…

New online! Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment

18.02.2025 03:44 πŸ‘ 10 πŸ” 2 πŸ’¬ 0 πŸ“Œ 1

100%.

Publishers’ profits are colossal and these APC figures speak to that.

27.01.2025 11:20 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
When care causes harm: a systematic review of adverse experiences in mental health wards - National Elf Service New review takes a broad approach to understanding and categorising adverse inpatient experiences, informing how best to respond to prevent harms.

When care causes harm: a systematic review of adverse experiences in mental health wards www.nationalelfservice.net?p=210756

#MentalHealthCare #InpatientCare #Harm #PatientExperiences #Qualitative #Seclusion #Restraint #Coercion #Safety #Dignity #Respect #MentalHealthServiceDesign

16.01.2025 15:48 πŸ‘ 25 πŸ” 18 πŸ’¬ 1 πŸ“Œ 3
Preview
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh - Harm Reduction Journal Background Scotland currently has amongst the highest rates of drug-related deaths in Europe, leading to increased advocacy for safer drug consumption facilities (SDCFs) to be piloted in the country. ...

🚨 New paper: β€˜The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh’

harmreductionjournal.biomedcentral.com/articles/10....

14.01.2025 09:57 πŸ‘ 7 πŸ” 11 πŸ’¬ 1 πŸ“Œ 0

My very last issue (on ♿️) has now come out with BMJ Medical Humanities: I have stepped down from my role as Editor in Chief. There are a lot of factorsβ€”after 17 years editing two consecutive journals, it was time. But there’s more, and I feel we should talk about the climate of #academic publishing

09.01.2025 12:31 πŸ‘ 418 πŸ” 187 πŸ’¬ 18 πŸ“Œ 82
Trend chart showing rate of alcohol deaths in England per 100,000 between 2006 and 2023. Shows rise from 10.8 per 100,000 in 2019 to 15.0 per 100,000 in 2023. A rise of 39% (and an absolute increase in numbers of 42%). 

Data from https://fingertips.phe.org.uk/profile/local-alcohol-profiles/data#page/4/gid/1938132984/pat/159/par/K02000001/ati/15/are/E92000001/iid/91380/age/1/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

Trend chart showing rate of alcohol deaths in England per 100,000 between 2006 and 2023. Shows rise from 10.8 per 100,000 in 2019 to 15.0 per 100,000 in 2023. A rise of 39% (and an absolute increase in numbers of 42%). Data from https://fingertips.phe.org.uk/profile/local-alcohol-profiles/data#page/4/gid/1938132984/pat/159/par/K02000001/ati/15/are/E92000001/iid/91380/age/1/sex/4/cat/-1/ctp/-1/yrr/1/cid/4/tbm/1

Today's OHID data shows the number of deaths caused by alcohol in England have now risen for *five years in a row* and are 40% higher than pre-pandemic.

England hasn't had an alcohol strategy for over a decade.

The case for action has never been stronger πŸ‘‡
www.telegraph.co.uk/global-healt...

03.12.2024 18:17 πŸ‘ 59 πŸ” 34 πŸ’¬ 4 πŸ“Œ 5

Report published in @AddictionJrnl here: onlinelibrary.wiley.com/doi/10.1111/...

30.12.2024 09:18 πŸ‘ 15 πŸ” 11 πŸ’¬ 1 πŸ“Œ 0
Video thumbnail

If you hate statistics like I do, then you'll love my free lectures. Putting science before statistics, 20 lectures from basics of inference & causal modeling to multilevel models & dynamic state space models. It's all free, made with love and sympathy. πŸ§ͺ #stats www.youtube.com/playlist?lis...

19.09.2024 10:56 πŸ‘ 851 πŸ” 229 πŸ’¬ 29 πŸ“Œ 26

This is why funders should pay for project managers. For my recent multinational, 5-year project across 4 countries, NIH cut our only 0.5 administrator - so now all admin needs to be done by the researchers. Crazy.

05.01.2025 14:26 πŸ‘ 137 πŸ” 30 πŸ’¬ 11 πŸ“Œ 3
Preview
Leveraging Old Hepatitis C Therapies | NEJM Older drugs could potentially advance U.S. hepatitis C elimination efforts. The government could act like a business and use all current and historical market information to its advantage.

Leveraging old hepatitis C therapies

via @nejm.org

www.nejm.org/doi/full/10....

#LiverSky #HepSky #IDSky

02.01.2025 07:19 πŸ‘ 9 πŸ” 4 πŸ’¬ 2 πŸ“Œ 0
Post image

NEW: Is the NHS still good value for money?

Billions of pounds are being ploughed into Britain’s health service β€” with little noticeable improvement in health since 2019.

Critics say the NHS has become bloated and inefficient. Is it?

@thetimes.com

πŸ”— www.thetimes.com/article/1130...

1/7

29.12.2024 11:25 πŸ‘ 161 πŸ” 80 πŸ’¬ 26 πŸ“Œ 31
LJMU Drug Related Deaths conference 2025 slide image

LJMU Drug Related Deaths conference 2025 slide image

We're pleased to announce that our LJMU Drug Related Deaths Conference 2025 will take place online on Friday 28th March. Previous events have seen some great discussions and networking so we expect a really worthwhile event. Registration is now open here: ims.ljmu.ac.uk/DRDconference #DRDevent

19.12.2024 12:57 πŸ‘ 3 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
Post image Post image

🚨 New review in @natrevgastrohep.bsky.social:
Should you take probiotics with antibiotics?
www.nature.com/articles/s41...

Bottom line: current evidence does not support the common perception that probiotics can facilitate the gut microbiome's recovery from antibiotics. BUT! 1/🧡

13.12.2024 23:34 πŸ‘ 58 πŸ” 24 πŸ’¬ 1 πŸ“Œ 3